Immune checkpoint inhibition: from molecules to clinical application

L. S. Taams; T. D. de Gruijl

doi:10.1111/cei.13434

Immune checkpoint inhibition: from molecules to clinical application

L. S. Taams^*
, T. D. de Gruijl

^*Corresponding author for this work

King's College London

Research output: Contribution to journal › Editorial › Academic › peer-review

18 Downloads (Pure)

Original language	English
Pages (from-to)	105-107
Number of pages	3
Journal	Clinical and experimental immunology
Volume	200
Issue number	2
DOIs	https://doi.org/10.1111/cei.13434
Publication status	Published - 1 May 2020

Access to Document

10.1111/cei.13434

cei13434.pdfFinal published version, 119 KB

Cite this

@article{0678fa9e8218449881d6a87637a609eb,

title = "Immune checkpoint inhibition: from molecules to clinical application",

author = "Taams, \{L. S.\} and \{de Gruijl\}, \{T. D.\}",

year = "2020",

month = may,

day = "1",

doi = "10.1111/cei.13434",

language = "English",

volume = "200",

pages = "105--107",

journal = "Clinical and experimental immunology",

issn = "0009-9104",

publisher = "Wiley Blackwell",

number = "2",

}

TY - JOUR

T1 - Immune checkpoint inhibition

T2 - from molecules to clinical application

AU - Taams, L. S.

AU - de Gruijl, T. D.

PY - 2020/5/1

Y1 - 2020/5/1

UR - https://www.scopus.com/pages/publications/85083466407

U2 - 10.1111/cei.13434

DO - 10.1111/cei.13434

M3 - Editorial

C2 - 32297327

SN - 0009-9104

VL - 200

SP - 105

EP - 107

JO - Clinical and experimental immunology

JF - Clinical and experimental immunology

IS - 2

ER -

Immune checkpoint inhibition: from molecules to clinical application

Access to Document

Other files and links

Cite this